159 related articles for article (PubMed ID: 1951872)
1. The effect of prophylaxis with chloroquine and proguanil on delayed-type hypersensitivity and antibody production following vaccination with diphtheria, tetanus, polio, and pneumococcal vaccines.
Gyhrs A; Pedersen BK; Bygbjerg I; Henrichsen J; Heron I; Petersen I; Skinhoj P
Am J Trop Med Hyg; 1991 Nov; 45(5):613-8. PubMed ID: 1951872
[TBL] [Abstract][Full Text] [Related]
2. [Serum antibodies before and after vaccination of hemodialyzed children. Preliminary results].
Margolis A; Kleinknecht C; Bonnissol C; Gaiffe M; Sahyoun S; Broyer M
J Urol Nephrol (Paris); 1977 Sep; 83(9):700-4. PubMed ID: 926232
[No Abstract] [Full Text] [Related]
3. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
[TBL] [Abstract][Full Text] [Related]
4. Humoral immune response to tetanus-diphtheria vaccine given during extended use of chloroquine or primaquine malaria chemoprophylaxis.
Fryauff DJ; Cryz SJ; Widjaja H; Mouzin E; Church LW; Sutamihardja MA; Richards AL; Subianto B; Hoffman SL
J Infect Dis; 1998 Jun; 177(6):1762-5. PubMed ID: 9607867
[TBL] [Abstract][Full Text] [Related]
5. Models for assessing the effect of toxicants on immunocompetence in mice. Part I: The effect of diphtheria, pertussis, and tetanus vaccine on antibody response to type III pneumococcal polysaccharide.
Speirs R; Benson RW; Schiffman G
J Environ Pathol Toxicol; 1978; 1(5):689-99. PubMed ID: 31407
[TBL] [Abstract][Full Text] [Related]
6. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
7. Routine immunizations in adult renal transplant recipients.
Huzly D; Neifer S; Reinke P; Schröder K; Schönfeld C; Hofmann T; Bienzle U
Transplantation; 1997 Mar; 63(6):839-45. PubMed ID: 9089223
[TBL] [Abstract][Full Text] [Related]
8. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
Speirs RS; Benson RW; Knowles BJ; Roberts D
J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
[TBL] [Abstract][Full Text] [Related]
9. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
[TBL] [Abstract][Full Text] [Related]
10. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
11. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
[TBL] [Abstract][Full Text] [Related]
12. Relationship between cutaneous delayed hypersensitivity and cell-mediated immunity in vitro responses assessed by diphtheria and tetanus toxoids.
Galant SP; Flod N; Shimizu I; Granger GA; Groncy CE
J Allergy Clin Immunol; 1977 Oct; 60(4):247-53. PubMed ID: 332750
[No Abstract] [Full Text] [Related]
13. In vivo and in vitro humoral immunity in surgical patients: antibody response to pneumococcal polysaccharide.
Nohr CW; Latter DA; Meakins JL; Christou NV
Surgery; 1986 Aug; 100(2):229-38. PubMed ID: 3488597
[TBL] [Abstract][Full Text] [Related]
14. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A
Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
[TBL] [Abstract][Full Text] [Related]
16. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
17. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients.
Opravil M; Fierz W; Matter L; Blaser J; Lüthy R
Clin Exp Immunol; 1991 May; 84(2):185-9. PubMed ID: 2025948
[TBL] [Abstract][Full Text] [Related]
18. Immunization of man with salmonella vaccine and tetanus-diphtheria vaccine. Dose-response relationship, secondary response, and competition of antigens.
Clasener HA
J Hyg (Lond); 1967 Dec; 65(4):457-66. PubMed ID: 5235253
[No Abstract] [Full Text] [Related]
19. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Findlow H; Borrow R; Booy R
Vaccine; 2018 Jul; 36(29):4375-4382. PubMed ID: 29880243
[TBL] [Abstract][Full Text] [Related]
20. In vivo cell-mediated immunity and vaccination response following prolonged, intense exercise.
Bruunsgaard H; Hartkopp A; Mohr T; Konradsen H; Heron I; Mordhorst CH; Pedersen BK
Med Sci Sports Exerc; 1997 Sep; 29(9):1176-81. PubMed ID: 9309628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
